TABLE 2.

Number of participants screened, enrolled, and finishing follow-up and characteristics at baseline as part of therapeutic efficacy monitoring in Angola in 2019

Parameter	Value for arm
	Benguela		Zaire		Lunda Sul
	AL	ASAQ	AL	ASAQ	AL	ASAQ
No. of participants screened	682	806	475	450	468	735
No. enrolled	105	100	100	100	100	105
No. lost to follow-up (%)	2 (2)	1 (1)	3 (3)	5 (5)	4 (4)	5 (5)
No. excluded (%)	2 (2)	1 (1)	2 (2)	4 (4)	1 (1)	1 (1)
No. reaching study endpoint (%)	101 (96)	98 (98)	95 (95)	91 (91)	95 (95)	99 (94)
Participant characteristics at baseline
Median age (yrs) (range)	6.5 (0.9–12)	7.5 (0.5–12)	2.8 (0.5–5)	2.8 (0.5–5)	3 (0.8–5)	3.4 (0.7–5)
Median wt (kg) (range)	18 (9–32)	20 (7–42)	12 (6–21)	12 (6–18)	12 (7–18)	13 (7–23)
% female participants	43	47	54	53	48	47
Median day 0 parasitemia (no. of parasites/μl) (range)	19,114 (1,030–97,313)	35,847 (1,048–95,067)	37,352 (2,284–198,595)	44,467 (2,087–196,176)	26,159 (2,120–193,346)	27,066 (2,190–186,419)
Median day 0 hemoglobin level (g/dl) (range)	10.7 (8.1–13.9)	10.4 (8.1–14.3)	10.6 (8–13.5)	10.8 (8.1–13.4)	10 (8.1–13.3)	10.4 (8.2–13.5)
Start mo-end mo	Mar-May	Mar-Apr	Mar-Apr	Mar-May	Mar-May	Mar-Jul